These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 4256250)
41. [Cardiac glycosides]. Pankratov AB Med Sestra; 1978 Mar; 37(3):34-40. PubMed ID: 247167 [No Abstract] [Full Text] [Related]
42. [Letter: Glycoside requirement in the normal ECG]. Klepzig H Med Klin; 1973 Oct; 68(41):1342. PubMed ID: 4765406 [No Abstract] [Full Text] [Related]
43. [Progress in the internistic treatment of heart diseases]. Aschenbrenner R Anglo Ger Med Rev; 1967 Dec; 4(1):200-8. PubMed ID: 5590772 [No Abstract] [Full Text] [Related]
45. [Proscillaridin A in some senile heart diseases. Preliminary clinico-therapeutic observations]. Guerricchio G; Basile F; Tantalo L Minerva Med; 1966 May; 57(43 Suppl):1982-90. PubMed ID: 5943256 [No Abstract] [Full Text] [Related]
46. Cor Pulmonale. Including a short note on pulmo cordis (cardiac lung disease). Robin ED; Gaudia R Dis Mon; 1970 May; ():3-38. PubMed ID: 4914931 [No Abstract] [Full Text] [Related]
47. [Values of calcium electrolytes in patients treated with cardiac glycosides]. Surbat L Med Pregl; 1975; 28(5-6):217-9. PubMed ID: 1160831 [No Abstract] [Full Text] [Related]
48. [Cardiogenic shock caused by pulmonary gas embolism with cardiac arrest. Resuscitation]. Oprişoni V; Ene V; Hudiţeanu D Chirurgia (1951); 1974 Jan; 23(1):83-9. PubMed ID: 4819819 [No Abstract] [Full Text] [Related]
51. [Experience in the use of cardiac glycosides in children with heart diseases]. Landa NM; Shcherbatova EI Vopr Okhr Materin Det; 1971 Jun; 16(6):69-73. PubMed ID: 5112039 [No Abstract] [Full Text] [Related]
52. [Therapy with cardiac glycosides]. Klepzig H Med Klin; 1969; 64(35):1533-5. PubMed ID: 5354486 [No Abstract] [Full Text] [Related]
53. [The significance of phase analysis in the pharmacotherapeutic control of the effect of cardiac glycosides]. Belostochnaia NG Ter Arkh; 1967 Apr; 39(4):65-7. PubMed ID: 5610908 [No Abstract] [Full Text] [Related]
54. [Are cardiac glycosides recommended following an attack of encephalomalacia?]. Aschenbrenner R Dtsch Med Wochenschr; 1968 Jan; 93(1):48. PubMed ID: 5635032 [No Abstract] [Full Text] [Related]
55. [Structure and effect of cardiac glycosides from the clinical viewpoint]. Sundermann A; Fiehring H Dtsch Gesundheitsw; 1967 May; 22(20):919-23. PubMed ID: 5600800 [No Abstract] [Full Text] [Related]
56. [Some clinical observations on the use of a cardiokinetic extract of squill: proscillaridin A. Differences from other more commonly used glycosides]. Luise A Minerva Med; 1967 Dec; 58(96):4286-9. PubMed ID: 6083290 [No Abstract] [Full Text] [Related]
57. [List of prescriptions for cardiotonic therapy]. Fanelli V Clin Ter; 1977 Dec; 83(6):657-60. PubMed ID: 608314 [No Abstract] [Full Text] [Related]
58. [Contribution to the quantitative and qual-itative study on the glycoside proscillaridin]. Wülfing von der Heyden D Med Welt; 1969 Mar; 13():738-43. PubMed ID: 5784356 [No Abstract] [Full Text] [Related]
59. [The preoperative care in noncardiac surgery of patients with heart failure]. Böhm M Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S70-6. PubMed ID: 10535050 [No Abstract] [Full Text] [Related]
60. [Rational use of cardiac glycosides in certain diseases in childhood]. Sidel'nikov VM; Afanas'ev EN; Liutkevich VF Pediatr Akus Ginekol; 1975; (3):3-6. PubMed ID: 1230764 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]